AtriCure (ATRC) Shares Outstanding (2010 - 2026)

AtriCure (ATRC) has 17 years of Shares Outstanding data on file, last reported at $50.6 million in Q1 2026.

• Quarterly Shares Outstanding rose 2.31% year-over-year to $50.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.6 million (up 2.31% YoY) and the FY2025 annual result came in at $49.8 million, up 1.89% from the prior year.
• Shares Outstanding climbed to $50.6 million in Q1 2026 per ATRC's latest filing, from $49.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $50.6 million in Q1 2026 and bottomed at $46.3 million in Q1 2022.
• The 5-year median for Shares Outstanding is $48.4 million (2024), against an average of $48.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding gained 1.11%; it then increased 2.86% in 2024.
• Tracing ATRC's Shares Outstanding over 5 years: stood at $46.6 million in 2022, then grew by 2.07% to $47.5 million in 2023, then advanced by 2.83% to $48.9 million in 2024, then rose by 1.89% to $49.8 million in 2025, then gained by 1.69% to $50.6 million in 2026.
• Per Business Quant, the three latest ATRC Shares Outstanding figures stand at $50.6 million (Q1 2026), $49.8 million (Q4 2025), and $49.7 million (Q3 2025).

Peer Comparison